{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T15:10:25Z","timestamp":1778512225040,"version":"3.51.4"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.nmd.2016.03.009","type":"journal-article","created":{"date-parts":[[2016,4,8]],"date-time":"2016-04-08T12:08:50Z","timestamp":1460117330000},"page":"370-373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["No relevant excess prevalence of myotonic dystrophy type 2 in patients with suspected fibromyalgia syndrome"],"prefix":"10.1016","volume":"26","author":[{"given":"J.","family":"van Vliet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Verrips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.A.","family":"Tieleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Scheffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.A.","family":"Cats","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.A.","family":"den Broeder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.G.M.","family":"van Engelen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2016.03.009_bib0010","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1212\/WNL.44.8.1448","article-title":"Proximal myotonic myopathy: a new dominant disorder with myotonia, muscle weakness, and cataracts","volume":"44","author":"Ricker","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2016.03.009_bib0015","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1212\/01.WNL.0000054481.84978.F9","article-title":"Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum","volume":"60","author":"Day","year":"2003","journal-title":"Neurology"},{"issue":"5531","key":"10.1016\/j.nmd.2016.03.009_bib0020","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1126\/science.1062125","article-title":"Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9","volume":"293","author":"Liquori","year":"2001","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.nmd.2016.03.009_bib0025","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.nmd.2009.04.012","article-title":"Left ventricular dysfunction and cardiac arrhythmias are frequent in type 2 myotonic dystrophy: a case control study","volume":"19","author":"Wahbi","year":"2009","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"10.1016\/j.nmd.2016.03.009_bib0030","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s004150050359","article-title":"Myotonic dystrophy and proximal myotonic myopathy","volume":"246","author":"Ricker","year":"1999","journal-title":"J Neurol"},{"issue":"7","key":"10.1016\/j.nmd.2016.03.009_bib0035","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/ejhg.2011.23","article-title":"Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland","volume":"19","author":"Suominen","year":"2011","journal-title":"Eur J Hum Genet"},{"issue":"6","key":"10.1016\/j.nmd.2016.03.009_bib0040","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.nmd.2006.03.010","article-title":"140th ENMC International Workshop: Myotonic Dystrophy DM2\/PROMM and other myotonic dystrophies with guidelines on management","volume":"16","author":"Udd","year":"2006","journal-title":"Neuromuscul Disord"},{"issue":"10","key":"10.1016\/j.nmd.2016.03.009_bib0045","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1007\/s00415-013-6993-0","article-title":"Diagnostic odyssey of patients with myotonic dystrophy","volume":"260","author":"Hilbert","year":"2013","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.nmd.2016.03.009_bib0050","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/art.1780380104","article-title":"The prevalence and characteristics of fibromyalgia in the general population","volume":"38","author":"Wolfe","year":"1995","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.nmd.2016.03.009_bib0055","first-page":"2270","article-title":"Fibromyalgia syndrome","volume":"32","author":"Mease","year":"2005","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.nmd.2016.03.009_bib0060","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1001\/archneur.61.12.1938","article-title":"Musculoskeletal pain in patients with myotonic dystrophy type 2","volume":"61","author":"George","year":"2004","journal-title":"Arch Neurol"},{"issue":"8","key":"10.1016\/j.nmd.2016.03.009_bib0065","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.nmd.2008.05.010","article-title":"Gastrointestinal involvement is frequent in Myotonic Dystrophy type 2","volume":"18","author":"Tieleman","year":"2008","journal-title":"Neuromuscul Disord"},{"issue":"9","key":"10.1016\/j.nmd.2016.03.009_bib0070","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1136\/jnnp.2009.192591","article-title":"Poor sleep quality and fatigue but no excessive daytime sleepiness in myotonic dystrophy type 2","volume":"81","author":"Tieleman","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.1016\/j.nmd.2016.03.009_bib0075","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.nmd.2011.03.013","article-title":"Myotonic dystrophy type 2 (DM2) and related disorders report of the 180th ENMC workshop including guidelines on diagnostics and management 3\u20135 December 2010, Naarden, The Netherlands","volume":"21","author":"Udd","year":"2011","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2016.03.009_bib0080","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1186\/1471-2458-9-402","article-title":"General symptom reporting in female fibromyalgia patients and referents: a population-based case-referent study","volume":"9","author":"Bj\u00f6rkegren","year":"2009","journal-title":"BMC Public Health"},{"issue":"11","key":"10.1016\/j.nmd.2016.03.009_bib0085","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1002\/art.24037","article-title":"Myotonic dystrophy type 2 found in two of sixty-three persons diagnosed as having fibromyalgia","volume":"58","author":"Auvinen","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.nmd.2016.03.009_bib0090","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1136\/ard.2010.148577","article-title":"Tailored cognitive-behavioural therapy and exercise training improves the physical fitness of patients with fibromyalgia","volume":"70","author":"van Koulil","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.nmd.2016.03.009_bib0095","series-title":"ICD-9-CM, International classification of diseases, 9th revision, clinical modification","author":"CDC","year":"1979"},{"issue":"5","key":"10.1016\/j.nmd.2016.03.009_bib0100","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/acr.20140","article-title":"The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity","volume":"62","author":"Wolfe","year":"2010","journal-title":"Arthritis Care Res"},{"issue":"12","key":"10.1016\/j.nmd.2016.03.009_bib0105","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/ejhg.2012.108","article-title":"Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2","volume":"20","author":"Kamsteeg","year":"2012","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.nmd.2016.03.009_bib0110","series-title":"Aids to the examination of the peripheral nervous system, Memorandum 45","author":"Medical Research Council","year":"1976"},{"issue":"3","key":"10.1016\/j.nmd.2016.03.009_bib0115","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/art.20042","article-title":"Family study of fibromyalgia","volume":"50","author":"Arnold","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.nmd.2016.03.009_bib0120","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1086\/378720","article-title":"Myotonic dystrophy type 2: human founder haplotype and evolutionary conservation of the repeat tract","volume":"73","author":"Liquori","year":"2003","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.1016\/j.nmd.2016.03.009_bib0125","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1086\/378566","article-title":"Confirmation of the type 2 myotonic dystrophy (CCTG)n expansion mutation in patients with proximal myotonic myopathy\/proximal myotonic dystrophy of different European origins: a single shared haplotype indicates an ancestral founder effect","volume":"73","author":"Bachinski","year":"2003","journal-title":"Am J Hum Genet"},{"issue":"5","key":"10.1016\/j.nmd.2016.03.009_bib0130","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/ejhg.2010.233","article-title":"Dutch myotonic dystrophy type 2 patients and a North-African DM2 family carry the common European founder haplotype","volume":"19","author":"Coenen","year":"2011","journal-title":"Eur J Hum Genet"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096089661530136X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096089661530136X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:04:53Z","timestamp":1760774693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096089661530136X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S096089661530136X"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2016.03.009","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"No relevant excess prevalence of myotonic dystrophy type 2 in patients with suspected fibromyalgia syndrome","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2016.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}